Notably, FXR influences autophagy by inhibiting the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway, thereby impacting the malignant progression of colon cancer cells [205]. The gene discussed is NR1H4; the disease is malignant colon neoplasm.